Research Article
Interleukin-37b Suppressed ILC2s in Children with Allergic Rhinitis
Figure 4
The protein expression of IL-37b during subcutaneous allergen immunotherapy. (a) The comparison of IL-37b protein expression between baseline and 3 years after SCIT. (b) The comparison of IL-37b protein expression between poor and good response groups 3 years after SCIT. (c) The correlation between IL-37b protein expression and disease severity. SMS: symptom medication score; SCIT: subcutaneous allergen immunotherapy. Compared with the baseline group, .
(a) |
(b) |
(c) |